What is the most recent earnings date for PASG stock?
PASSAGE BIO INC (PASG) last reported earnings on 3/3/2026.
NASDAQ:PASG • US7027122099
Past quarterly earnings results for PASSAGE BIO INC (PASG), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -3.95 | -2.62 | -50.68% | 1.25% | - | - | ||
| Q3 2025 | -2.44 | -2.86 | 14.57% | 60.65% | - | - | ||
| Q2 2025 | -2.96 | -4.13 | 28.35% | 43.08% | - | - | ||
| Q1 2025 | -5.00 | -4.69 | -6.56% | 16.67% | - | - | ||
| Q4 2024 | -4.00 | -4.16 | 3.88% | 33.33% | - | - | ||
| Q3 2024 | -6.20 | -4.69 | -32.14% | 36.73% | 3.4M | -100.00% | - | |
| Q2 2024 | -5.20 | -6.32 | 17.77% | 40.91% | - | - | ||
| Q1 2024 | -6.00 | -7.29 | 17.73% | 52.38% | - | - | ||
| Q4 2023 | -6.00 | -8.20 | 26.80% | 38.78% | - | - | ||
| Q3 2023 | -9.80 | -9.31 | -5.31% | - | - | - | ||
| Q2 2023 | -8.80 | -9.76 | 9.81% | 39.73% | - | - | ||
| Q1 2023 | -12.60 | -10.10 | -24.71% | 20.25% | - | - | ||
| Q4 2022 | -9.80 | -10.66 | 8.11% | 48.42% | - | - | ||
| Q3 2022 | -9.80 | -16.13 | 39.26% | 43.68% | - | - | ||
| Q2 2022 | -14.60 | -16.86 | 13.41% | 18.89% | - | - | ||
| Q1 2022 | -15.80 | -18.11 | 12.75% | -3.95% | - | - | ||
| Q4 2021 | -19.00 | -18.08 | -5.09% | -11.76% | - | - | ||
| Q3 2021 | -17.40 | -17.58 | 1.01% | -38.10% | - | - | ||
| Q2 2021 | -18.00 | -15.44 | -16.58% | -50.00% | - | - | ||
| Q1 2021 | -15.20 | -15.18 | -0.15% | 24.00% | - | - | ||
| Q4 2020 | -17.00 | -14.34 | -18.59% | - | - | - | ||
| Q3 2020 | -12.60 | -15.50 | 18.73% | - | - | - | ||
| Q2 2020 | -12.00 | -11.63 | -3.20% | - | - | - | ||
| Q1 2020 | -20.00 | -9.11 | -119.49% | - | - | - |
Notes
PASSAGE BIO INC (PASG) last reported earnings on 3/3/2026.
PASSAGE BIO INC (PASG) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, PASSAGE BIO INC (PASG) has beaten EPS estimates in 2 out of 4 releases.